Home

China

World

Politics

Business

Sci-Tech

Health

Opinions

Video

Live

Radio

World Asia-Pacific Middle East Europe Americas Africa

By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.

I agree

00:41

With China's 15th Five-Year Plan (2026–2030) unlocking massive opportunities for global enterprises by prioritizing high-quality growth and domestic consumption, UK-based company Haleon is strengthening its commitment to this dynamic market with a £65 million ($86 million) investment in a new state-of-the-art oral health manufacturing site in Shanghai. This strategic expansion aims to capture surging demand in China's fast-growing tier-2 and tier-3 cities, where rising incomes and a heightened focus on "better daily health" are driving consumers toward trustworthy brand products.

As affirmed by Brian McNamara, CEO of Haleon, this move underscores Haleon's long-term confidence in China, aligning corporate growth with the nation's broader vision for health innovation and economic resilience.

Open in CGTN APP for better experience

Search Trends

Investing in China: Global businesses expand footprint in booming health market